We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Devastating Neurological Disorder Caused by Single Gene Mutation

By Biotechdaily staff writers
Posted on 16 Jun 2008
A new study has shown that the single gene mutation responsible for Rett syndrome ultimately affects the function of more than 2500 other genes.

Rett syndrome has a distinctive onset and course. More...
The affected child—almost always a girl—develops normally during the first five months of life. After the fifth month, head growth slows down and the child loses whatever purposeful hand movements she had developed during her first five months. After 30 months, the child frequently develops repetitive hand washing or hand wringing gestures; 50–80% of children with the disorder will eventually have seizures. Rett syndrome is also associated with varying degrees of mental retardation.

Rett syndrome is caused by the failure of the infant's brain to develop normally. This developmental failure is in turn associated with a mutation in the MECP2 gene, which resides on the far end of the longest arm of the X chromosome.

After failing to establish a cause and effect relationship between the MECP2 mutation and the large variety of symptoms displayed by Rett syndrome victims by studying overall gene function in the brain, investigators at Baylor College of Medicine (Houston, TX, USA) decided to focus their attention on the hypothalamus region of the brains of laboratory mice. They studied both Rett syndromes, where MECP2 fails to function, and a newly identified mutation where MECP2 is duplicated and its protein product overexpressed.

Results published in the May 30, 2008, issue of the journal Science revealed that both disorders changed the expression of about 2,500 genes. In the animals with Rett syndrome, 2,200 genes were less active than they were in normal mice, while the remainder showed increased activity. The numbers were precisely reversed in the duplication syndrome.

"From a practical viewpoint, knowing how the two syndromes behave on a molecular level is really important,” said senior author Dr. Huda Zoghbi, professor of molecular genetics at Baylor College of Medicine. "The duplication syndrome and Rett syndrome may share many clinical symptoms, but on the level of the neuron they are totally different, and so the treatment would be totally different.”

"Rett syndrome is a devastating disease,” said Dr. Zoghbi. "Think about what it takes to function normally: You have to be coordinated, you must be able to think, you have to be able to communicate, and you need to move smoothly and with balance. The symptoms of other neurological diseases affect some of these functions, but Rett syndrome affects them all. Rett syndrome is particularly heartbreaking, because it develops after the child has already learned to walk, and perhaps even say a few words. To lose all that, and gradually develop a symptom from almost every neurological disease in the book is quite mind-boggling.”


Related Links:
Baylor College of Medicine

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.